Trial Search Results

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation

The purpose of this study is to demonstrate the safety and effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheters with Contact Force Sensing Capability in the treatment of drug refractory symptomatic paroxysmal Atrial Fibrillation (AF) during standard electrophysiology mapping and RF procedures.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Biosense Webster, Inc.

Stanford Investigator(s):

Intervention(s):

  • Device: THERMOCOOL® SMARTTOUCH™ Catheter

Phase:

Phase 3

Eligibility


Inclusion Criteria:

   - Have had at least 3 atrial fibrillation episodes within 6 months of this study

   - Have failed at least one antiarrhythmic drug shown by repeated atrial fibrillation
   episodes

   - 18 years of age or older

Exclusion Criteria:

   - Have had previous ablation for atrial fibrillation

   - Have take amiodarone within 6 months of this study

   - Have had any heart surgery within the last 60 days

   - Have had a heart attack within the last 60 days

   - Females who are pregnant or breast feeding

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Linda Norton, RN, MSN
(650)725-5597
Not Recruiting